Cancer Immunotherapy Guidelines Prostate Carcinoma Subcommittee

SITC Cancer Immunotherapy Guidelines are a collection of consensus statements developed by experts in the treatment of specific types of cancer. Each consensus statement provides key indicators to help practicing oncologists determine when and how to best use immunotherapy to treat their patients. These systematically developed recommendations promote enhanced clinical decisions concerning patient selection, toxicity management, clinical endpoints, and the sequencing or combination of therapies. The Prostate Cancer Task Force was developed to generate a consensus statement specifically for prostate cancer.

Chair

James L. Gulley, MD, PhD, FACP
National Cancer Institute

Co-Chair

Douglas G. McNeel, MD, PhD
Carbone Cancer Center, University of Wisconsin-Madison

Current Members
2 Members